Birdwatch Note
2024-11-29 00:52:08 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
These claims grossly misrepresent the effectiveness of chemotherapy. The 97% failure rate for chemotherapy is false and not supported by scientific evidence: https://www.logicallyfacts.com/en/fact-check/no-chemotherapy-does-not-have-a-failure-rate-of-97-percent https://firstcheck.in/fact-check-does-chemotherapy-have-a-failure-rate-of-97/ Survival and Chemotherapy Success: https://www.medicalnewstoday.com/articles/326031#lung-cancer https://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/how-is-chemotherapy-used-to-treat-cancer.html Testicular cancer and Hodgkin lymphoma have high cure rates: https://www.cancer.org/cancer/types/testicular-cancer/treating/chemotherapy.html https://www.ncbi.nlm.nih.gov/books/NBK563159/ https://www.pnas.org/doi/full/10.1073/pnas.072067999 https://www.cancer.org/cancer/types/hodgkin-lymphoma/treating/chemotherapy.html https://www.cancerresearchuk.org/about-cancer/hodgkin-lymphoma/survival https://www.cancer.org/cancer/types/hodgkin-lymphoma/detection-diagnosis-staging/survival-rates.html
Written by 8E0782E7F593AE43DE132F9A686B9623FE5078AF96C0655960B8BBFA4E740320
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1862250275148370336
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1862298466665603255
- noteId - 1862298466665603255
- participantId -
- noteAuthorParticipantId - 8E0782E7F593AE43DE132F9A686B9623FE5078AF96C0655960B8BBFA4E740320 Participant Details
- createdAtMillis - 1732841528942
- tweetId - 1862250275148370336
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- These claims grossly misrepresent the effectiveness of chemotherapy. The 97% failure rate for chemotherapy is false and not supported by scientific evidence: https://www.logicallyfacts.com/en/fact-check/no-chemotherapy-does-not-have-a-failure-rate-of-97-percent https://firstcheck.in/fact-check-does-chemotherapy-have-a-failure-rate-of-97/ Survival and Chemotherapy Success: https://www.medicalnewstoday.com/articles/326031#lung-cancer https://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/how-is-chemotherapy-used-to-treat-cancer.html Testicular cancer and Hodgkin lymphoma have high cure rates: https://www.cancer.org/cancer/types/testicular-cancer/treating/chemotherapy.html https://www.ncbi.nlm.nih.gov/books/NBK563159/ https://www.pnas.org/doi/full/10.1073/pnas.072067999 https://www.cancer.org/cancer/types/hodgkin-lymphoma/treating/chemotherapy.html https://www.cancerresearchuk.org/about-cancer/hodgkin-lymphoma/survival https://www.cancer.org/cancer/types/hodgkin-lymphoma/detection-diagnosis-staging/survival-rates.html
Note Ratings
rated at | rated by | |
2024-11-30 10:14:02 -0600 | Rating Details | |
2024-11-29 00:44:29 -0600 | Rating Details | |
2024-11-28 23:45:57 -0600 | Rating Details | |
2024-11-28 22:55:56 -0600 | Rating Details | |
2024-11-28 21:51:06 -0600 | Rating Details | |
2024-11-28 20:19:14 -0600 | Rating Details | |
2024-11-28 20:10:17 -0600 | Rating Details | |
2024-11-28 20:07:28 -0600 | Rating Details | |
2024-11-28 20:06:25 -0600 | Rating Details | |
2024-11-28 20:04:08 -0600 | Rating Details | |
2024-11-28 20:04:03 -0600 | Rating Details | |
2024-11-28 19:55:03 -0600 | Rating Details | |
2024-11-28 19:54:22 -0600 | Rating Details | |
2024-11-28 19:53:50 -0600 | Rating Details | |
2024-11-28 19:53:32 -0600 | Rating Details | |
2024-11-28 19:03:18 -0600 | Rating Details | |
2024-11-30 20:34:36 -0600 | Rating Details | |
2024-11-28 20:21:08 -0600 | Rating Details | |
2024-11-28 19:51:49 -0600 | Rating Details | |
2024-11-28 19:13:21 -0600 | Rating Details | |
2024-11-28 19:01:27 -0600 | Rating Details | |
2024-12-02 00:38:50 -0600 | Rating Details | |
2024-11-29 15:44:36 -0600 | Rating Details | |
2024-11-28 20:09:50 -0600 | Rating Details | |
2024-11-28 19:57:50 -0600 | Rating Details | |
2024-11-28 19:42:10 -0600 | Rating Details | |
2024-11-28 19:31:13 -0600 | Rating Details | |
2024-11-28 19:04:21 -0600 | Rating Details | |
2024-11-28 18:56:07 -0600 | Rating Details |